CCL20 and psoriasis: In several animal models of psoriasis, the use of anti‐TNF‐α antibody infliximab,247 anti‐CCR6 antibody,248 and the anti‐CCL20 antibody,249 respectively, significantly reduced regional infiltration of CCR6+CD4+ T cells and attenuated the inflammatory response in affected skin lesions.